The QUIDEL Group B Strep Test is an enzyme immunoassay (EIA) that was compared with culture for the rapid detection of moderate to high levels of group B streptococci (GBS) colonization in pregnant women. A total of 331 pregnant women were included in the study protocol, and GBS were cultured from 19 (2, 3, 13, 15) .
The QUIDEL Group B Strep Test is an enzyme immunoassay (EIA) that was compared with culture for the rapid detection of moderate to high levels of group B streptococci (GBS) colonization in pregnant women. A total of 331 pregnant women were included in the study protocol, and GBS were cultured from 19 (8) . The reservoir for the transmission of GBS to the newborn is the birth canal, where colonization rates range from 5 to 30% in pregnant women (6) . Importantly, over 80% of systemic GBS infections occur in premature infants, with the primary risk factors being prolonged labor or the premature rupture of membranes (2, 3, 13, 15) .
Antepartum culture of the birth canal has been used to identify pregnant women colonized with GBS. However, subsequent treatment of antepartum patients having positive cultures has not been cost-effective, and recolonization is common (1, 16) . In recent years, several studies have shown that the intrapartum treatment of GBS-colonized women significantly reduces the incidence and mortality associated with neonatal GBS sepsis (4, (10) (11) (12) 18 The cultural recovery of GBS in moderate or greater amounts was the interpretative criterion used in determining whether a patient had GBS infection. An important aspect of this EIA is that it is not designed to detect low levels (less NOTES than 10 colonies per plate) of GBS because the manufacturer believes that low levels of GBS colonization do not constitute a significant risk factor for the development of neonatal infection. Accordingly, specimen cultures that grew low numbers of GBS were regarded as negative on the basis of these guidelines. Standard methods (14) were used to calculate the statistical parameters of sensitivity, specificity, and positive and negative predictive values.
A total of 333 vaginal or cervical samples were processed in this study. Two samples were excluded from the study group because one specimen clogged the test cartridge membrane filter and the other gave an uninterpretable result. Both of these samples gave negative cultural results for GBS. Of the remaining 331 specimens, GBS were recovered from culture in moderate or greater amounts from 19 specimens for an overall disease prevalence of 5.7%. Of the 312 specimens that were regarded as negative by culture, 4 actually grew low numbers of GBS. On the basis of the study guidelines, however, these cultures were regarded as negative and they also gave negative EIA results. Only two false-positive and two false-negative EIA results were observed. Of the two false-negative EIA samples, both grew moderate numbers of GBS on culture. Compared with culture, the EIA had a sensitivity, specificity, and positive and negative predictive values of 89, 99, 89, and 99%, respectively. The overall test correlation of EIA with culture was 98.8%.
The vertical transmission of GBS can be successfully interrupted by the prophylactic administration of ampicillin to all women in labor (3, 18) . However, the indiscriminate chemoprophylaxis of these women prior to delivery is neither practical nor necessary. Even though the incidence of neonatal GBS disease may be reduced by this practice, the risk of developing antibacterial resistance, adverse maternal and/or fetal drug reactions, and other complications outweighs the benefits of such chemoprophylactic measures (12) .
Routine culture has been the traditional method of identifying GBS-colonized patients. However, as mentioned previously, conventional culture is a time-consuming process in which results are not usually available for 24 to 72 h. Therefore, routine culture is not a practical solution to the problem of identifying colonized patients as candidates for chemoprophylaxis.
As an alternative to routine culture, several more rapid methods, such as the use of selective-enrichment broth (10, 12) , latex agglutination assay (5, 9, 12) , and Gram stained smear (7, 17) , have been developed and/or evaluated for selectively screening intrapartum mothers for GBS colonization. The use of any of these tests significantly reduces the time period for the availability of the final report compared with using routine culture. Unfortunately, none of the tests have sufficient sensitivity and/or specificity to assure the accuracy of their results (5, 7, 9, 10, 12, 17 
